Pfizer testing Omicron-based vaccine amid concerns about twin variant
Pfizer is now testing its new Omicron-based shot. Pfizer CEO Dr. Albert Bourla said: “We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variance.” In a news release, the drug maker announced its trial includes fourteen hundred healthy adults inContinue Reading










